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Background: A large number of essential oils is reported to have significant activity against Candida albicans. But
the different chemical composition influences the degree of their activity. The intention of this study was to
investigate the chemical composition and the activity against Candida albicans of volatile oils obtained from
Artemisia dracunculus, A. abrotanum, A. absinthium and A. vulgaris (Asteraceae). The aim of the study was to identify
new chemical compounds that have effect against C. albicans.
The essential oils were obtained by hydrodistillation or extraction with dichloromethane (a new procedure we
developed trying to obtain better, more separated compounds) from air dried above ground plant material and
analyzed by GC-MS. Additionally commercial essential oils from the same species were tested. The Candida albicans
inhibition studies were carried out by the paper disc diffusion method.
Results: The essential oils shared common components but presented differences in composition and showed
variable antifungal activity. Davanone and derivatives thereof, compounds with silphiperfolane skeleton, estragole,
davanone oil, β-thujone, sabinyl acetate, herniarin, cis-chrysanthenyl acetate, 1,8-cineol, and terpineol were the main
components of Artemisia volatiles.
Conclusions: Among the volatile fractions tested those from A. abrotanum containing davanone or silphiperfolane
derivatives showed the highest antifungal activity. The in vitro tests revealed that the Artemisia oils are promising
candidates for further research to develop novel anti-candida drugs.
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The genus Artemisia belongs to one of the largest and
most widely distributed genera of the family Asteraceae
(Compositae). It is a diverse and economically important
genus and it has more than 500 species. Most plants
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article, unless otherwise stated.foodstuff, ornamentals or soil stabilizers, some are aller-
genic or toxic, and some are weeds growing in the fields
[1-4].
Antimycotic activity of A. absinthium against Candida
albicans was reported in several in vitro studies [5,6] how-
ever, there are also investigations that found no such activ-
ity [7-10].
The conditions that may separate these studies are the
plant preparations put under investigation. The highest
percentage of successful antifungal activity of Artemisiantral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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erally showed less activity [5-10].
More information on the potential antifungal activity
of Artemisia plants could stimulate research leading to
their possible future use in the clinical treatment of can-
didiasis as natural antimycotic agents.
Results and discussion
In the present study, the chemical composition and the
antifungal in vitro potency of seven oil preparations ob-
tained from air dried plants and commercial essential oil
samples of 4 different Artemisia species were put under
investigation. Their chemical composition was evaluated
by GC-MS. The antifungal activity was determined by
the disk diffusion method test. The tests were done
using the disc diffusion method following CLSI standard
rules for antimicrobial susceptibility testing of impreg-
nated disks [11].
Chemical composition
The volatile fractions studied showed a great chemical di-
versity. All four Artemisia species had distinct volatile pat-
terns and there were also differences in the composition
between the two different extracts, the distilled oil and the
CH2Cl2 extract, of the same species, as presented in
Table 1.
A. abrotanum was characterized by the high content of
the sesquiterpene davanone and its derivatives which
could not all be identified as well as by the artedouglasia
oxides A-D. Monoterpenes like 1-terpineol or trans-piper-
itol and the phenylpropanoid estragole were present in
small amounts only in this species. All main compounds
found in the distilled oil were also present in the CH2Cl2
extract. The davanone derivatives were also the main com-
pounds in the microdiostillates which also contained the
artedouglasia oxides.
The main compound in the distilled oil of A. dracunculus
was estragole accounting for approximately 80% of the oil.
However, in the CH2Cl2 extract this compound could not
be identified. Small amounts of the phenylpropanoids cha-
vicol and methyleugenol could be found. These extracts
contained also some davanone and its derivatives. Both, the
distilled oil and the extract contained the coumarin deriva-
tive herniarin. In the microdistillate, the main compounds
were estragole (79.5%) followed by Z-β-ocimene (8.8%) and
E-β-ocimene (7.2%).
From A. absinthium only a CH2Cl2 extract was ob-
tained. The main peak in the chromatogram could not be
identified. Furthermore, the extract contained β-thujone
and nerol as major compounds and estragole, spathulenol
and α-bisabolol as further components. Herniarin was also
present in this extract. The microdistillate was character-
ized by the presence of β-thujone (78.1%), sabinene (4.4%),
and myrcene (4.4%).The main volatiles in A. vulgaris were terpinen-4-ol,
and borneol. One noticeable difference between the two
volatile preparations was that 1,8-cineol, the main com-
pound in the oil from the CH2Cl2 extract, was not found
in the distilled oil.
The composition of the commercial Artemisia essential
oils samples is displayed in Table 2. In contrast to the own
preparations of A. abrotanum oils, the commercial sample
was dominated by the sesquiterpene silphiperfolene deriva-
tives and contained appreciable amounts of 1,8-cineol
(21.7%, 168 mg/ml), borneol (8.2%, 64 mg/ml) and p-cymene
(6.9%, 54 mg/ml). The A. dracunculus sample had estra-
gol as main compound and the ocimene isomers similar
to the microdistillation fingerprint of the own material
from the botanical garden. The commercial A. absinthium
sample had β-thujone (41%, 358 mg/g), sabinyl acetate
(22%, 153 mg/g) and α-thujone (13%, 113 mg/ml) as main
compounds. Finally, the purchased A. vulgaris essential oil
was rich in α-thujone (65%, 531 mg/g), camphor (14%,
110 mg/g), and β-thujone (10%, 79 mg/g).Test microorganisms
The anticandidal test with the commercial oils is pre-
sented in Table 3. All four oils showed anticandidal activity
with A. abrotanum being the most efficient, followed by
A. absinthium, A. dracunculus and A. vulgaris.
The four investigated Artemisia species revealed distinct
volatile patterns. A comparison with published data showed
that even within one and the same species the oil compos-
ition may vary widely, representing different chemotypes.
For instance, A. abrotanum from Cuba had trans-sabinyl
acetate and α-terpineol as main oil compounds [12]. The
same species collected in Serbia displayed silphiperfol-5-en-
3-one A (14.6%), ascaridole (13.1%), 1,8-cineole (10.5%), α-
bisabolol oxide A acetate (8.7%) as main oil components
[13]. Similarly, an oil from Northwestern Italy had 1,8-cine-
ole (34.7%), bisabolol oxide (18.4%) and ascaridole (16.0%)
as main compounds [14]. The dominant components in
the oil from the Crimea were 1,8-cineole and camphor [15].
A German A. abrotanum showed 1,8-cineol as main oil
compound [16]. Plant cultivated in Poland were rich in
piperitone (17.5%), davanone (16.8%), 1,8-cineole (12.5%)
and silphiperfol-5-en-3-ol A (6.3%). These plants contained
also the artedouglasia oxides as minor compounds [17].
The present oil of A. dracunculus and the oils reported in
literature were dominated by phenylpropanoids. A Polish
oil sample contained elemicin (48.8%), sabinene (18.9%),
isoelemicin (13.3%) and eugenol (7.6%) [17], different
Finnish French tarragon contained cis- and trans-ocimenes,
estragole and herniarin [18], and Crimean samples sabinene
and elemicine [19]. Canadian A. dracunculus essential oil
was mainly composed of methyl eugenol (35.8%), eugenol
(16.2%) and terpinolene (19.1%) [20].
Table 1 GS-MS chemical composition of the volatiles from the investigated Artemisia species














1. 969 4-Methyl-pent-2-enolid 15.7 (1.7869) 1.7 (0.1379) - 1.8 (0.046) - - -
2. 991 1-Octen-3ol - - - - - - 4.2 (0.253)
3. 1037 1,8-Cineol - - - - - - 18 (1.077)
4. 1043 Z-β-Ocimene - - 1.3 (0.103) - - - -
5. 1044 Lavender lactone 2.6 (0.3017) - - - - - -
6. 1053 E-β-Ocimene - - 1.6 (0.124) - - - -
7. 1069 cis-Arbusculone 0.7 (0.0885) - - - - - -
8. 1077 trans-Arbusculone 0.6 (0.0738) - - - - - -
9. 1100 trans-Sabinene hydrate - - - - - 3.5 (0.079) -
10. 1114 Phenylethyl alcohol - - - - - 1.8 (0.042) 2.1 (0.129)
11. 1122 β-Thujone - - - - 14.7 (0.380) - -
12. 1129 1-Terpineol 1.6 (0.1817) - - - - - -
13. 1132 allo Ocimene - - 0.3 (0.028) - - - -
14. 1141 iso-3-Thujanol - - - - 2.2 (0.059) - -
15. 1147 cis-β-Terpineol 1.2 (0.1402) 0.8 (0.0700) - - - - -
16. 1152 Camphor - - - - - - 5.6 (0.337)
17. 1173 Borneol - - - - - 5.4 (0.122) 13.2 (0.792)
18. 1183 Terpinen-4-ol - - - - - 18.2 (0.407) 13.5 (0.801)
19. 1189 p-Cymen-8-ol - - - - - - 1.9 (0.113)
20. 1195 α-Terpineol - - - - - 10 (0.223) 6.6 (0.394)
21. 1202 Estragole 0.9 (0.1123) 0.8 (0.0702) 84.1 (6.406) - 5 (0.126) -
22. 1211 trans-Piperitol 1.2 (0.1454) - - - - - -
23. 1221 trans-Carveole - - - - - 1.9 (0.043) -
24. 1226 Nerol - - - - 11.5 (0.297) - -
25. 1227 Nordavanone, 3 (0.3414) 5.4 (0.4275) - 8.3 (0.206) - - -
26. 1252 Geraniol - - - - 2.6 (0.069) - -
27. 1253 Chavicol - 0.4 (0.031) 1 (0.023) - - -
28. 1257 Piperitone 0.5 (0.0616) - - - - - -
29. 1260 cis-Chrysanthenylacetate - - - - 2.5 (0.065) - 15 (0.897)
30. 1292 Cuminol - - - - 7.2 (0.163) 1.7 (0.105)
31. 1299 UnknownABS 29.1 (0.750)














Table 1 GS-MS chemical composition of the volatiles from the investigated Artemisia species (Continued)
33. 1354 Eugenol - 1.4 (0.107) 1.4 (0.036) 0.9 (0.023) 3.8 (0.086) 3 (0.175)
34. 1367 UnknownABR1 5.2 (0.4115) - - - - -
35. 1386 E-Methylcinnamate - - 0.9 (0.068) - - - -
36. 1399 Methyleugenol - 2.2 (0.173) 1.4 (0.035) 1.5 (0.040) - -
37. 1401 UnknownABR2 1.3 (0.1540)
38. 1422 UnknownABR3 20.7 (1.6363) 4.3 (0.106)
39. 1466 γ-Decalactone - - 0.2 (0.015) - - - -
40. 1483 Germacrene D - - 0.2 (0.015) - - 0.5 (0.011) 1.6 (0.091)
41. 1484 Davanone ether 0.9 (0.1016) - - - - -
42. 1486 Farnesene - - - - - - 1(0.062)
43. 1491 β-Selinene - - - - - - 1.2 (0.076)
44. 1500 Bicyclogermacrene - - 0.1 (0.012) - - - -
45. 1504 Davana ether* 3.2 (0.3591) - - - - - -
46. 1518 Artedouglasia oxide C 1.7 (0.1932) 1.1 (0.0869) 1.7 (0.042)
47. 1520 δ-Cadinene - - - - - - 1.5 (0.093)
48. 1522 Davana ether* 1.4 (0.1581) - - - - - -
49. 1531 Artedouglasia oxide A 2.2 (0.2575) 1.8 (0.1486) - 3.4 (0.084) - - -
50. 1554 Artedouglasia oxide D 1 (0.1201) 0.6 (0.0534) - 1 (0.023) - - -
51. 1476 Artedouglasia oxide B 1.3 (0.1469) 1 (0.0858) - 1.6 (0.040) - - -
52. 1580 cis-Davanone 5.2 (0.5989) 7.4 (0.5896) 0.6 (0.048) 9.1 (0.225) - - -
53. 1589 Spathulenol - - - - 6.5 (0.168) 12.1 (0.271) 7.1 (0.425)
54. 1585 Caryophyllene oxide - - - - 2.8 (0.072) 8.5 (0.191) 2.7 (0.163)
55. 1598 UnknownABR4 - 2 (0.1582) - - - - -
56. 1599 UnknownABR5 1.3 (0.1570) - - - - - -
57. 1641 UnknownABR6 2.7 (0.3121) - - - - - -
58. 1655 Bisabololoxide B - - - - 3.3 (0.086) - -
59. 1656 epi-α Muurolol - - - - - 11.8 (0.265) -
60. 1684 α-Bisabolol - - - 11 (0.285) - -
61. 1685 UnknownABR7 12.4 (1.4113) 17.2 (1.3599) 0.5 (0.041) 20.5 (0.506) - - -
62. 1688 UnknownABR8 4 (0.4598) - - - - - -
63. 1711 UnknownABR9 8.7 (0.9892) - - 3.4 (0.085) - - -
64. 1719 Herniarin, - - 4.3 (0.329) 10 (0.246) 5.8 (0.150) - -














Table 1 GS-MS chemical composition of the volatiles from the investigated Artemisia species (Continued)
66. 1936 UnknownDRA - - 0.3 (0.029) 7 (0.174) - - -
67. 1963 Hexadecanoic acid - - - - - 11.2 (0.249) -
68. 2107 Phytol-isomer 1.2 (0.1451) - 1.1 (0.087) (0.138) - - -
* exact isomer not determined, RI retention index.
Mass spectra of the unidentified compounds.
RI 1367 UnknownABR1: 41 (50), 43 (72), 44 (13), 45 (14), 53 (15), 55 (100), 56 (13), 57 (30), 67 (32), 68 (13), 69 (37), 71 (41), 74 (11), 81 (19), 83 (14), 84 (11), 85 (11), 93 (37), 95 (25), 111 (34), 123 (10), 169 (46).
RI 1299 UnknownABS: 41 (39), 43 (68), 44 (8), 53 (16), 55 (22), 57 (14), 59 (100), 67 (49), 68 (19), 69 (9), 71 (34), 77 (11), 79 (32), 81 (45), 82 (55), 83 (12), 89 (11), 93 (7), 94 (7), 109 (10), 152 (11).
RI 11401 UnknownABR2: 55 (100), 41 (70), 43 (100), 44 (25), 53 (16), 56 (14), 57 (55), 59 (26), 67 (31), 69 (44), 71 (34), 77 (12), 81 (29), 83 (26), 85 (19), 91 (18), 93 (96), 95 (15), 97 (20), 111 (68), 125 (15), 126 (26).
RI 1422 UnknownABR3: 41 (32), 43 (62), 53 (13), 55 (83), 57 (10), 67 (24), 68 (14), 69 (28), 71 (100), 72 (14), 77 (10), 81 (24), 83 (16), 91 (14), 93 (74), 95 (9), 100 (19), 110 (11), 111 (94), 125 (18), 195 (11).
RI 1598 UnknownABR4: 41 (9), 42 (3), 43 (10), 44 (3), 53 (4), 55 (13), 57 (6), 67 (5), 68 (3), 69 (5), 71 (4), 79 (2), 81 (4), 83 (5), 85 (100), 86 (5), 93 (9), 107 (2), 111 (3), 114 (12), 156 (4).
RI 1599 UnknownABR5: 41 (38), 43 (100), 44 (14), 55 (30), 57 (25), 69 (22), 71 (17), 77 (14), 79 (20), 81 (32), 83 (22), 85 (20), 91 (15), 93 (18), 95 (17), 109 (45), 149 (14), 161 (15), 207 (46), 219 (21), 234 (15).
RI 1641 UnknownABR6: 41 (52), 43 (68),44 (13), 53 (18), 55 (100), 56 (13), 57 (29), 67 (27), 68 (18), 69 (37), 71 (23), 79 (12), 81 (27), 83 (32), 84 (17), 85 (12), 91 (12), 93 (72), 95 (24), 109 (13), 111 (73).
RI 1685 UnknownABR7: 41 (38), 43 (40), 53 (9), 55 (53), 57 (10), 67 (15), 68 (10), 69 (43), 71 (18), 77 (6), 81 (17), 83 (20), 91 (9), 93 (64), 94 (7), 95 (8), 97 (9), 111 (100), 112 (12), 125 (19), 140 (13).
RI 1688 UnknownABR8: 41 (62), 43 (100), 53 (15), 55 (82), 57 (23), 67 (31), 68 (28), 69 (43), 70 (16), 71 (77), 72 (19), 79 (12), 81 (31), 82 (15), 83 (20), 91 (13), 93 (93), 94 (14), 95 (24), 110 (15), 111 (76), 113 (13), 125 (20).
RI 1711 UnknownABR9: 43 (100), 93 (66), 55 (55), 111 (55), 113 (51), 85 (39), 41 (35), 69 (30), 67 (26), 95 (25), 81 (24), 125 (20), 57 (20), 71 (19), 97 (17), 96 (17), 109 (14), 83 (14), 68 (14), 138 (11), 53 (11), 236 (5).
RI 1754 Davanone-derivative: 41 (45). 43 (100), 53 (17), 55 (74), 57 (24), 67 (32), 68 (14), 69 (45), 71 (36), 79 (18), 81 (48), 82 (12), 83 (23), 91 (12), 93 (87), 95 (20), 96 (29), 97 (48), 109 (20), 111 (90), 112 (12), 113 (15), 125
(69), 236 (36).














Table 2 Composition of the commercial Artemisia essential oils (mg/ml)








1 800 Octane - 0.1 (0.8) 01. (0.9)
2 927 Tricyclene 0.08 (0.6) 0.1 (0.8)
3 932 α-Thujene - 0.03 (0.3)
4 939 α-Pinene 0.1 (1.1) 1.4 (11.9) 0.3 (2.9) 0.1 (1.0)
5 953 Camphene 2.7 (18.5) 0.05 (0.5) 0.1 (1.2) 2.2 (18.0)
6 978 Sabinene 0.1 (0.9) 0.07 (0.6) 2 (16.1) 1.8 (15.2)
7 982 β-Pinene 0.3 (2.3) 0.1 (1.5) 0.3 (2.6) 0.2 (1.6)
8 993 Myrcene 0.1 (0.9) 6.4 (6.5)
9 1008 α-Phellandrene 0.2 (1.6)
10 1021 α-Terpinene 0.9 (6.4)
11 1030 p-Cymene 7.8 (53.5) 0.1 (1.4) 0.7 (6.3)
12 1034 Limonene 4 (33.8) 0.4 (3.4)
13 1037 1,8-Cineol 24.5 (167.9) 1.5 (12.3) 0.6 (5.1)
14 1042 Z-β-Ocimene 8.3 (69.5)
15 1053 E-β-Ocimene 7.8 (65.5)
16 1064 γ-Terpinene 0.4 (3.1) 0.1 (1.0)
17 1073 cis-Sabinene hydrate 0.3 (2.0) 0.02 (0.2)
18 1092 Terpinolene 0.1 (0.7)
19 1093 Fenchone 0.3 (3.0)
20 1102 Linalool 2 (16.4)
21 1102 trans-Sabinene hydrate 0.3 (2.4) 0.07 (0.6)
22 1110 α-Thujone 13. (112.5) 65.5 (530.5)
23 1122 β-Thujone 44 (357.6) 9 (73.2)
24 1126 Dehydro sabinaketone 1.5 (12.8)
25 1132 allo-Ocimene 0.1 (1.0)
26 1136 Z-Epoxyocimene 1.5 (12.9)
27 1146 trans-Sabinol 3 (24.2)
28 1146 trans-Pinocarveol 0.5 (4.1)
29 1146 neo-allo-Ocimene 0.07 (0.6)
30 1152 Camphor 3.5 (24.2) 0.8 (7.2) 13.6 (110.4)
31 1165 Sabina ketone 0.3 (2.4)
32 1171 Isoborneol 0.8 (6.6)
33 1173 Borneol 9.3 (63.8) 0.4 (3.9)
34 1183 Terpinen-4-ol 1.8 (12.7) 0.3 (2.9) 0.5 (4.4)
35 1195 α-Terpineol 0.2 (1.5)
36 1201 Myrtenal 0.37 (2.6) 0.4 (3.2)
37 1202 Estragol 75 (626.1)
38 1235 Isobornylformate 0.1 (1.3)
39 1240 Fenchyl acetate 0.1 (0.8)
40 1247 trans-Chrysanthenyl acetate 1 (7.2)
41 1248 Cuminal 0.1 (1.0)
42 1257 Piperitone 0.2 (1.6)
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Table 2 Composition of the commercial Artemisia essential oils (mg/ml) (Continued)
43 1266 Verbenyl acetate 0.4 (3.4)
44 1291 Bornyl acetate 0.7 (5.2) 0.07 (0.6)
45 1291 Anethol 1.5 (12.7)
46 1292 Lavandulyl acetate 0.4 (3.7)
47 1296 Sabinyl acetate 23.7 (193.2)
48 1334 Silphiperfol-5-ene 0.7 (5.3)
49 1346 Silphiperfolen-Isomer 0.5 (3.9)
50 1353 7 β-H-Silphiperfol-5-ene 0.6 (4.4)
51 1367 Silphiperfol-4, 7(14)-diene 0.3 (2.6)
52 1369 Silphiperfolen-Isomer 0.7 (5.0)
53 1384 α-Copaene 0.1 (1.4) 0.07 (0.6)
54 1408 Z-Methyl-isoeugenol 0.2 (2.2)
55 1425 Linalyl isobutyrate 0.2 (1.7)
56 1429 β-Caryophyllene 0.7 (5.3) 0.05 (0.5) 1.4 (11.8)
57 1464 α-Humulene 1.8 (1.3) 0.1 (1.1)
58 1483 Germacrene D 3.4 (23.5) 0.05 (0.5)
59 1497 Farnesene 0.04 (0.4)
60 1500 Bicyclogermacrene 0.05 (0.5) 0.3 (2.4)
61 1507 Farnesene 0.03 (0.3)
62 1512 Lavandulyl isovalerate 0.7 (5.9)
63 1513 Unknown 5.7 (39.4)
64 1531 β-Sesquiphellandrene 0.05 (0.5)
65 1531 Unknown 1.7 (12.1) 0.1 (0.9)
66 1548 Siphiperfol-5-en-3-one B 2.7 (19.1)
67 1558 Silphiperfol-5-en-3-one B-isomer 5.1 (35.2)
68 1583 Silphiperfol-5-en-3-one A 18.9 (129.5)
69 1589 Spathulenol
70 1595 Unknown 3 (20.1)
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ition of A. absinthium L. was obtained and examined from
different geographical parts of Europe the Absithii herba
(plant) can be divided into at least 4 chemotypes: thujones
rich oil (Greece, Spain, Ukraine, France, Italy), sabinene
acetate rich oil (Armenia, Latvia, Belgium, Lithuania), epox-
yocimenes rich oil (Russia), and a chemotype in which oilTable 3 Inhibitory in vitro effects of the commercial
Artemisia essential oils on Candida albicans (ATCC 10231)
Essential oil Inhibition zone
diameter (mm ± SD)
A. dracunculus 15.5 ± 2.1
A. abrotanum 20.0 ± 1.4
A. absinthium 17.0 ± 1.4
A. vulgaris 12.5 ± 0.7
Nystatin (positive control) 15.0 ± 0
Blank filter paper (negative control) 6.0 ± 0monoterpenes sabinene and myrcene were predominant
(Estonia, Scotland, Moldova, Hungary). This is partly in ac-
cordance with a former study [22] where 19 samples of A.
absinthium from Italy, France, Romania, and Siberia were
divided into four chemotypes: sabinyl acetate rich oil, epox-
yocimenes rich oil, chrysanthenyl acetate rich oil, and thu-
jone rich oil. An epoxy-ocimene rich oil was also found in
northwestern Italy [14]. An oil rich in t-sabinylacetate,
thujone and myrcene is reported from Canada [20]. Fur-
thermore a Turkish A. absinthium oil had chamazulene
and nuciferol esters as major compounds [23].
Cited literature [5,15] described an A. absinthium oil
rich in thujone and in the aerial parts of A.vulgaris an
oil with high proportions of 1,8-cineole, sabinene, thu-
jone, and caryophyllene oxide.
Essential oils from A. vulgaris rich in camphor, 1,8 cineole
or β-thujone have been described [14,24-26]. These oils
contain also chrysanthenyl acetate, borneol, methyleugenol,
α-terpineol, t-verbenol, or β caryophyllene but owing to the
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chemotypes. The A. vulgaris volatile fraction in the present
study contained terpinen-4-ol, borneol, cis-chrysanthenyl
acetate, and spathulenol as major compounds.
In this study, all volatile fractions isolated from all four
Artemisia species showed some activity against Candida
albicans. The highest activity was found for A. abrotanum
where an inhibition zone larger than that produced by Ny-
statin could be observed. But it has to be considered that
these fractions contain higher amounts of potentially active
compounds than the fractions obtained from the other in-
vestigated species. Nevertheless, there are reports confirm-
ing the antimycotic activity of the main compounds
identified by GC-MS in the present volatile fractions.
An extract from A. abrotanum grown in Sweden as well
as the component davanone were effective against C. albi-
cans [27]. Furthermore, davana oil from Artemisia pallens
rich in davanone and the davana fraction derived from this
oil were active against Candida albicans [28]. However in
another study, davanone as single compound showed only
very weak in vitro activity against C. albicans [29]. Can-
dida albicans proved to be very susceptible against the es-
sential oil from Ocimum selloi which contains more than
95% estragole (= methylchavicol) [30]. However, in an-
other test series, estragole as single substance proved to be
ineffective [31].
In the present study, 1,8-cineol, borneol, terpinen-4-ol,
spathulenol, β-thujone, and α-bisabolol were major com-
pounds in all of the volatile fractions of A. absinthium and
A. vulgaris studied. The oils containing these compounds
can be found in various plants and some of them were re-
ported to inhibit the growth of C. albicans. An essential oil
rich in α-pinene and α-bisabolol from Laserpitium zernyi
showed a low activity against two strains of C. albicans [32].
The oil of A. annua containing 48% camphor as main com-
pound was active against C. albicans [33]. A sage (Salvia
officinalis) oil from Montenegro with the main com-
pounds α-thujone (29.5%), camphor (22.5%) and 1,8-cine-
ole (12.2%) had significant activity against C. albicans [34].
Oils from sage, myrtle, and laurel containing 1,8-cineol
as main compound showed some activity against C. albi-
cans [35], also an Eucalyptus oil with 85% of 1,8-cineole
content [36]. However an Egyptian oil from Eucalyptus
occidentalis that presumably contained 1,8 cineole had
no influence on the growth of C. albicans [37].
Additionally, 7-methoxycoumarin (herniarin) isolated
from twigs of Treculia obovoidea showed some activity
against various Candida species [38]. Although reports on
the antifungal activity of Artemisia species are inconsistent
the results of this study confirm that Artemisia essential oils
exert antimycotic effects and may represent good candi-
dates to replace in the future allopathic treatments to which
Candida has developed resistance. Under the conditions of
this study, volatile fractions from A. abrotanum as well asthe commercial oil from this plant had the strongest effect
on Candida albicans although they differed in composition,
having either davanone derivatives or silphiperfolene deriv-
atives and 1,8-cineol as major compounds, respectively.
The differences in activity and order in efficacy of the oils
and volatile preparations most probably arises from differ-
ences in composition. So the own A. vulgaris preparations
containing a mix of 1,8-cineol, terpinen-4-ol, borneol, cam-
phor, and spathulenol were more active than the commer-
cial oil with the thujones and camphor. The lower activity
of the A. absinthium dichloromethane extract might be due
to the lower overall concentration of active compounds in
this preparation as compared to the commercial sample
from the same species.
Experimental research
Plant material
The A. abrotanum, A. dracunculus, and A. absinthium
aerial parts were collected in the Botanical Garden of the
University of Veterinary Medicine Vienna, Austria. A. vul-
garis aerial parts were gathered in the surroundings of Ti-
misoara (Bencecul de Sus), Romania. All plants were
picked during the June-September period of 2010, while
blooming. Voucher specimen of the collected plants were
deposited in the Herbarium of the University of Vienna
(WU-Generale, http:\\herbarium.univie.ac.at).
Commercial essential oils
Additionally, other commercial essential oils from Arte-
misia absinthium (USA), A. dracunculus (Iran), and A.
vulgaris (Marokko) were obtained from Baccara Rose
(Dagmar Köhler, 47665 Sonsbeck, Germany). Artemisia
abrotanum came from Ayus GmbH, 77815 Bühl/Moos,
Germany.
Test microorganisms
Isolates of Candida albicans (ATCC 10231) were ob-
tained from the culture collection of the Department of
Microbiology, Banat’s University of Agricultural Sciences
and Veterinary Medicine Timisoara.
Methods
The preparation of the essential oils was done using a
modified standard procedure according to the European
Pharmacopoeia [39]. The procedures were done at the
same period of time. The plant material (15 g) was sub-
jected to hydrodistillation using 150 ml distilled water
for 4 hours at a constant rate. An average of 18.5 mg of
essential oil was obtained.
In addition, an extraction with dichloromethane
(CH2Cl2) followed by hydrodistillation was carried out.
100 g of fresh plant material (leaves or flowers) were ex-
tracted 5 times with 100 ml of CH2Cl2 in consecutive
steps. The resulting extracts were combined and the
Table 4 Inhibitory in vitro effects of the volatile fractions
on Candida albicans (ATCC 10231)
Volatile fraction Inhibition zone
diameter (mm ± SD)
A. dracunculus (oil) 15.5 ± 1.52
A. dracunculus (CH2Cl2) 13.0 ± 2.08
A. abrotanum (oil) 23.5 ± 1.52
A. abrotanum (CH2Cl2) 21.5 ± 3.51
A. absinthium (CH2Cl2) 13.0 ± 1.15
A. vulgaris (oil) 16.6 ± 1.57
A. vulgaris (CH2Cl2) 17.0 ± 1.15
Nystatin (positive control) 20.5 ± 4.04
Blank filter paper (negative control) 6.0 ± 0
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average yield was 2 g of crude extract; the pooled extract
was hydrodistillated for 3 hours as mentioned above and
stored at 4˚C until analysis. An average yield of 30 mg
oil out of 2 g extract was obtained. For further analyses
volatile oil from several preparations were combined.
Leaves of the plants collected from the botanical garden
were also subjected to microdistillation using the auto-
matic microdistillation unit MicroDistiller from Eppendorf
(Hamburg, Germany) which is a gentle distillation method
that allows investigating essential oil finger prints. The
procedure was as follows: 0.2 to 0.3 g finely crushed dried
plant material and 10 ml distilled water were filled into
the sample vial. The collecting vial containing 1 ml water,
0.5 g NaCl and 300 μl n-hexane was connected with a ca-
pillary to the sample vial. The heating program applied to
the sample vial was 15 min at 108°C followed by 45 min at
112°C. The collecting vial was kept at −2°C, where the vol-
atiles were trapped in 0.3 ml n-hexane.
Analysis of the essential oils
The analysis of the volatiles was performed using a
Hewlett-Packard 6890 GC linked to a Hewlett- Packard
5973 mass-selective detector. For the analysis a Zebron ZB-
5MS, capillary column (27 m× 250 μm i. d., 0.25 μm film
thickness) was used. The carrier gas was helium at 1.3 ml/
min in constant flow mode. The injector temperature was
250°C, the injection volume 1 μl, and the split ratio 1:20.
The initial oven temperature of 60°C was held for 1 minute,
then increased at a rate of 5°C/min up to 220°C, and subse-
quently at a rate of 15°C/min up to 280°C, and finally was
held isothermal for 1 min. The transfer line to the MSD
was set at 280°C and the scan conditions were: M/Z 40–
300, at 1.75 scans/sec.
Prior to analysis 900 μl of the volatile fractions were
mixed with 100 μl of biphenyl (2.0 mg/ml in hexane) as
internal standard. The components of essential oils were
identified by comparing their relative retention times and
mass spectra with those of Registry of Mass Spectral Data
and literature citations [40,41]. The amount of the individ-
ual compounds in the fractions was calculated using the
Total Ion Current from the MSD signal and assuming the
same response as for the internal standard biphenyl.
Inocula containing 106 cells/ml were spread on the
medium (Sabouraud with added penicillin (40 units/ml)
and streptomycin (2 mg/ml of medium)). The antifungal
activity test was carried out by the disk diffusion method
using sterilized 6 mm diameter filter paper disks. From
each volatile oil preparation a quantity of 50 μl was sub-
mitted to testing and the tests were done in triplicate.
The inoculated plates were incubated at 35°C for 24 h.
Standard bio discs of Nystatin 100 units/disk (Himedia
Laboratories Ltd., India) were used as positive control
and blank sterilized filter papers as negative control.After the incubation, the diameter of the inhibition zone
for each essential oil was measured in millimeters (includ-
ing the 6 mm diameter of the disk). The results are
expressed as mean values of three determinations ± S.D.
Antifungal activity in vitro
The experimental protocols were approved by the Animal
Ethics Committee of the Faculty of Veterinary Medicine
Timisoara and conducted accordingly. All 7 Artemisia
preparations were subjected to the disc diffusion test
against Candida albicans (ATCC 10231). Inhibition zones
observed ranged from 23.5 mm to 13 mm for the essential
oils and volatile oils. An 20.5 mm inhibition zone was de-
termined for Nystatin and 6 mm (the diameter of the bio-
disc) for the negative control (Table 4).
Highest antifungal activity was observed with A. abro-
tanum (both volatile fractions) followed by A. vulgaris,
A. dracunculus, and A. absinthium.
Conclusions
Since all volatile fractions caused inhibition we conclude
that compounds found in different quantities are respon-
sible for the varying in vitro-activity against C. albicans, but
it is difficult to attribute this effect of complex mixtures to
a particular constituent. Possibly synergistic as well as an-
tagonistic effects of compounds in the oil should also be
taken into consideration as often stronger antifungal activ-
ity can be observed with complete essential oils in compari-
son to single oil components [42]. Our studies showed that
different procedures for preparation of volatile fractions,
starting from extracts or plant material, resulted in different
chemical compositions. This phenomenon may contribute
to the contradictory results published for the antimycotic
effects of Artemisia. Under the conditions of this study,
volatile fractions from Artemisia plants exert antifungal
in vitro activity. Our results may open paths for the devel-
opment of new phytotherapeutic products from the Arte-
misia species studied.
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